ALKBH5 and neoplasm: The results indicate that during the 4-week treatment period, compared to the Control group, tumor volume and mass were significantly reduced in the ALKBH5-siRNA-BNVs group and NGR-ALKBH5-siRNA-BNVs group, with the NGR-ALKBH5-siRNA-BNVs group showing more pronounced inhibition.